Live Tracker

Maeve's Treatment Journey

High Risk B-ALL · CNS-Predominant (CNS3) · COG AALL1731/1732 · Children's Healthcare of Atlanta

DOB: Jul 19, 2023 ⚠️ Allergy: Amoxicillin 2–2.99 yrs → IT-MTX 10 mg
Day 55
of 314 active chemo days
21
Day of Consolidation
17.2%
Active chemo complete
260
Active chemo days left
Feb 4, 2026 — Diagnosis Dec 15, 2026 — Active Chemo Done
+ 730-day maintenance phase after chemo ends

Treatment Roadmap

Induction Done ✓
28 days
Feb 4 – Mar 3, 2026

Intensive 4-week phase to achieve remission. Combines multiple chemo agents.

Count Recovery Done ✓
6 days
Mar 4 – Mar 9, 2026

Short break for bone marrow to recover before Consolidation begins.

Consolidation NOW
56 days
Mar 10 – May 4, 2026

8-week phase to eliminate residual disease. Includes IT chemo directly to spinal fluid.

21 / 56 days · 35.7% complete

Blinatumomab #1
28 days
May 5 – Jun 1, 2026

4-week targeted immunotherapy. Engages your T-cells to hunt leukemia cells.

Interim Maintenance 1
56 days
Jun 2 – Jul 27, 2026

8-week oral chemo phase. Keeps remission while allowing recovery.

Blinatumomab #2
28 days
Jul 28 – Aug 24, 2026

Second round of targeted immunotherapy.

Delayed Intensification
56 days
Aug 25 – Oct 19, 2026

Re-intensification phase mirroring Induction. Critical for long-term cure.

Interim Maintenance 2
56 days
Oct 20 – Dec 14, 2026

Second 8-week oral chemo maintenance phase.

After Active Chemo ↓
Maintenance Post-Chemo
730 days
Dec 15 – Dec 13, 2028

2-year oral chemo phase. Daily 6-MP + weekly MTX. Near-normal life.

Drug Reference

Tap any drug pill in the calendar to jump directly here.

Medical Glossary

Terms you'll encounter throughout Maeve's treatment.